[
  {
    "ts": null,
    "headline": "ResMed: Snoozers Can Be Winners",
    "summary": "ResMedâs competitive edge is strong, but its current valuation seems inflated. Read why RMD stock might be ripe for profit-taking despite long-term growth.",
    "url": "https://finnhub.io/api/news?id=125beddb245e721604483cb32f44421433901a2378a7f2fbdee194339dce423c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738398551,
      "headline": "ResMed: Snoozers Can Be Winners",
      "id": 132510232,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1689585474/image_1689585474.jpg?io=getty-c-w1536",
      "related": "RMD",
      "source": "SeekingAlpha",
      "summary": "ResMedâs competitive edge is strong, but its current valuation seems inflated. Read why RMD stock might be ripe for profit-taking despite long-term growth.",
      "url": "https://finnhub.io/api/news?id=125beddb245e721604483cb32f44421433901a2378a7f2fbdee194339dce423c"
    }
  }
]